Tirzepatide + B12 (Injection)

$320.00

Tirzepatide is a dual-action medication that activates both GLP-1 and GIP receptors — two pathways involved in appetite, blood sugar, and metabolism. By working with both, it may reduce hunger more effectively than single-pathway therapies. Often chosen by patients who want a more comprehensive metabolic approach or who haven't seen the response they wanted on semaglutide alone. Our formulation includes B12 or B6. Compounded by a licensed 503A pharmacy based on your clinician's prescription.

What it may help with

  • Appetite and cravings — dual-pathway approach to reducing food noise
  • Portion control — may help you feel satisfied with smaller meals
  • Blood sugar balance — may support insulin response and steadier glucose
  • Sustainable weight loss — gradual results when paired with nutrition and lifestyle changes
  • Sleep apnea — the branded version (Zepbound) is FDA-approved for moderate-to-severe obstructive sleep apnea in adults with obesity

What's included

  • Clinician evaluation and prescription (when appropriate)
  • Compounded tirzepatide + B12/B6, prepared by a licensed 503A pharmacy
  • Injection supplies — vials, syringes, alcohol pads, sharps guidance
  • Discreet monthly shipping
  • Ongoing access to your Zyra care team for questions and dose adjustments

How it works

After purchase, you'll complete a medical intake online. A Zyra clinician reviews your history and determines whether tirzepatide is appropriate for you. If approved, your medication ships discreetly to your door — most patients receive their first order within one week. Monthly supply auto-renews every 4 weeks. Pause or cancel anytime.

Compounded tirzepatide is not an FDA-approved finished drug product. The FDA-approved versions (Mounjaro, Zepbound) are approved for type 2 diabetes, chronic weight management, and obstructive sleep apnea at specific doses and patient criteria. Results vary and are not guaranteed. Prescription required.

Tirzepatide is a dual-action medication that activates both GLP-1 and GIP receptors — two pathways involved in appetite, blood sugar, and metabolism. By working with both, it may reduce hunger more effectively than single-pathway therapies. Often chosen by patients who want a more comprehensive metabolic approach or who haven't seen the response they wanted on semaglutide alone. Our formulation includes B12 or B6. Compounded by a licensed 503A pharmacy based on your clinician's prescription.

What it may help with

  • Appetite and cravings — dual-pathway approach to reducing food noise
  • Portion control — may help you feel satisfied with smaller meals
  • Blood sugar balance — may support insulin response and steadier glucose
  • Sustainable weight loss — gradual results when paired with nutrition and lifestyle changes
  • Sleep apnea — the branded version (Zepbound) is FDA-approved for moderate-to-severe obstructive sleep apnea in adults with obesity

What's included

  • Clinician evaluation and prescription (when appropriate)
  • Compounded tirzepatide + B12/B6, prepared by a licensed 503A pharmacy
  • Injection supplies — vials, syringes, alcohol pads, sharps guidance
  • Discreet monthly shipping
  • Ongoing access to your Zyra care team for questions and dose adjustments

How it works

After purchase, you'll complete a medical intake online. A Zyra clinician reviews your history and determines whether tirzepatide is appropriate for you. If approved, your medication ships discreetly to your door — most patients receive their first order within one week. Monthly supply auto-renews every 4 weeks. Pause or cancel anytime.

Compounded tirzepatide is not an FDA-approved finished drug product. The FDA-approved versions (Mounjaro, Zepbound) are approved for type 2 diabetes, chronic weight management, and obstructive sleep apnea at specific doses and patient criteria. Results vary and are not guaranteed. Prescription required.